Clinical trial
Randomized , Placebo-controlled, Clinical Trial of Efficacy and Safety Evaluation of Guaifenesin, Doxylamine Succinate and Hydrochloride Etafedrine Syrup in Improving the Signs and Symptoms of Infections of Way Upper (URI)
NCT00857987 is registered in ClinicalTrials.gov with Azidus Brasil as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized , Placebo-controlled, Clinical Trial of Efficacy and Safety Evaluation of Guaifenesin, Doxylamine Succinate and Hydrochloride Etafedrine Syrup in Improving the Signs and Symptoms of Infections of Way Upper (URI)
- Lead sponsor
- Azidus Brasil
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- April 30, 2010
- Completion date
- December 31, 2011
- Enrollment
- 174 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
upper airway infections